PMC:7309518 / 1165-1441 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":69,"end":76},"obj":"Body_part"},{"id":"T6","span":{"begin":114,"end":127},"obj":"Body_part"},{"id":"T7","span":{"begin":132,"end":136},"obj":"Body_part"},{"id":"T8","span":{"begin":245,"end":257},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma82816"}],"text":"gainst GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral ner"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T27","span":{"begin":54,"end":62},"obj":"Disease"},{"id":"T28","span":{"begin":191,"end":201},"obj":"Disease"},{"id":"T29","span":{"begin":228,"end":236},"obj":"Disease"}],"attributes":[{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"gainst GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral ner"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":132,"end":136},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"gainst GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral ner"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":7,"end":11},"obj":"Chemical"},{"id":"T5","span":{"begin":69,"end":76},"obj":"Chemical"},{"id":"T6","span":{"begin":91,"end":102},"obj":"Chemical"},{"id":"T7","span":{"begin":98,"end":102},"obj":"Chemical"},{"id":"T8","span":{"begin":114,"end":127},"obj":"Chemical"},{"id":"T9","span":{"begin":152,"end":156},"obj":"Chemical"},{"id":"T10","span":{"begin":245,"end":257},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_28175"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_26667"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_28175"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"}],"text":"gainst GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral ner"}

{"project":"LitCovid-PubTator","denotations":[{"id":"55","span":{"begin":91,"end":102},"obj":"Chemical"},{"id":"56","span":{"begin":245,"end":257},"obj":"Chemical"},{"id":"69","span":{"begin":54,"end":62},"obj":"Disease"},{"id":"70","span":{"begin":184,"end":201},"obj":"Disease"},{"id":"71","span":{"begin":228,"end":236},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D019158"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:D005732"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:C000657245"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"MESH:D001039"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"gainst GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral ner"}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":7,"end":11},"obj":"GlycoEpitope"},{"id":"T2","span":{"begin":147,"end":156},"obj":"GlycoEpitope"},{"id":"T3","span":{"begin":152,"end":156},"obj":"GlycoEpitope"}],"attributes":[{"id":"A1","pred":"glyco_epitope_db_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0059"},{"id":"A2","pred":"glyco_epitope_db_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/AN0403"},{"id":"A3","pred":"glyco_epitope_db_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0059"}],"text":"gainst GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral ner"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T11","span":{"begin":191,"end":201},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0009830"}],"text":"gainst GD1b, instead of QG1b, were found; because the COVID-19 spike protein also binds to sialic acid-containing glycoproteins for cell-entry and anti-GD1b antibodies typically cause ataxic neuropathy, cross-reactivity between COVID-19–bearing gangliosides and peripheral ner"}